Clinical and pathophysiological issues associated with type 1 autoimmune pancreatitis.

Kazushige Uchida, Hideaki Miyoshi, Tsukasa Ikeura, Masaaki Shimatani, Makoto Takaoka, Kazuichi Okazaki

Open access · bronzeAbstract readReview

In one paragraph

Review in Clinical journal of gastroenterology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it

0cells of the map it votes in

5citing papers in PubMed

2.1field-weighted citation impact, top 14% of its field

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 10 citations in OpenAlex.

Cytokines and inflammatory mediators: Markers involved in interstitial damage to the pancreas in two dengue fever cases associated with acute pancreatitis.PloS one · 2022
Article
Response to the Letter by Poddighe et al. regarding our manuscript "Basophils activated via TLR signaling may contribute to pathophysiology of type 1 autoimmune pancreatitis".Journal of gastroenterology · 2018
Article
Basophils activated via TLR signaling may contribute to pathophysiology of type 1 autoimmune pancreatitis.Journal of gastroenterology · 2018
Article
From Pathogenesis, Clinical Manifestation, and Diagnosis to Treatment: An Overview on Autoimmune Pancreatitis.Gastroenterology research and practice · 2017
Review
Serological characteristics of autoimmune pancreatitis and its differential diagnosis from pancreatic cancer by using a combination of carbohydrate antigen 19-9, globulin, eosinophils and hemoglobin.PloS one · 2017
Article

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Kazushige UchidaDepartment of Gastroenterology and Hepatology, Kansai Medical University, 10-15 Shinmachi, Hirakata, Osaka, 573-1010, Japan. uchidak@hirakata.kmu.ac.jp.

Hideaki MiyoshiDepartment of Gastroenterology and Hepatology, Kansai Medical University, 10-15 Shinmachi, Hirakata, Osaka, 573-1010, Japan.

Tsukasa IkeuraDepartment of Gastroenterology and Hepatology, Kansai Medical University, 10-15 Shinmachi, Hirakata, Osaka, 573-1010, Japan.

Masaaki ShimataniDepartment of Gastroenterology and Hepatology, Kansai Medical University, 10-15 Shinmachi, Hirakata, Osaka, 573-1010, Japan.

Makoto TakaokaDepartment of Gastroenterology and Hepatology, Kansai Medical University, 10-15 Shinmachi, Hirakata, Osaka, 573-1010, Japan.

Kazuichi OkazakiDepartment of Gastroenterology and Hepatology, Kansai Medical University, 10-15 Shinmachi, Hirakata, Osaka, 573-1010, Japan.

Kansai Medical University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In 1995, Yoshida and colleagues proposed the concept of 'autoimmune pancreatitis' (AIP). Recently, it is accepted that the existence of two subtypes of AIP-type 1, which involves immunoglobulin G4 (IgG4) as the pancreatic manifestation of IgG4-related disease (IgG4-RD), and type 2, which is characterized by granulocytic epithelial lesions. Type 2 AIP is thought to be rare in Japan. In 2011, the International Consensus Diagnostic Criteria (ICDC) for autoimmune pancreatitis was proposed. In Japan, the clinical diagnostic criteria of AIP 2011 was proposed by the Japan Pancreas Society (JPS) and the Research Committee of Intractable Diseases of the Pancreas. The JPS 2011 is based on ICDC and a simplified checklist of items to diagnose type 1 AIP. Although recent progress in type 1 AIP has resolved clinical features, diagnosis, treatment, and pathogenesis, many clinical and basic issues still remain unclear. Here, we provide an overview of the recent clinical and basic issues associated with type 1 AIP.

Indexed as

Autoimmune DiseasesB-Lymphocytes, RegulatoryGlucocorticoidsHumansImmunoglobulin GPancreatitisPrognosisT-Lymphocytes, RegulatoryGlucocorticoidsImmunoglobulin GAutoimmune pancreatitisEUS-FNAIgG4M2 macrophageRegulatory B cellsRegulatory T cells

Identifiers

PMID26864047

DOI10.1007/s12328-016-0628-9

OpenAlexW2256688421

What OpenQuestion holds

Textmetadata

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.